Weight Loss Blood Test UK: What to Check Before, During & After Losing Weight

Why get blood tests before losing weight?

Willpower alone doesn’t determine whether you lose weight. Your thyroid controls your basal metabolic rate. Your insulin sensitivity determines how efficiently your body uses glucose instead of storing it as fat. Your cortisol levels influence where fat accumulates. Your vitamin D, iron, and B12 status affect energy, recovery, and motivation to exercise.

NICE guideline CG189 (Obesity: identification, assessment and management) recommends assessing comorbidities including blood lipids, HbA1c, blood pressure, and liver function as part of any structured weight management approach. Yet in practice, most GPs only run these tests after a BMI is flagged — not before you start trying to lose weight.

A baseline blood test gives you three things:

1. Rule out medical causes — hypothyroidism, insulin resistance, PCOS, and Cushing’s syndrome can all make weight loss significantly harder or impossible without treatment.
2. Establish your metabolic baseline — knowing your starting HbA1c, fasting insulin, lipids, and liver enzymes lets you measure genuine metabolic improvement, not just kilograms lost.
3. Avoid deficiency during restriction — calorie restriction and GLP-1 medications reduce appetite, which can accelerate existing vitamin D, iron, B12, and folate deficiencies.

What does a weight loss blood test check?

A comprehensive weight management panel should cover four domains: metabolic function, hormonal balance, nutritional status, and organ health. Here are the 12 markers that matter most:

The sections below explain each marker in detail, with NHS reference ranges, optimal targets, and what to do if your results are abnormal.

Thyroid function: the most common medical cause of unexplained weight gain

Your thyroid gland produces hormones that set your basal metabolic rate — the number of calories your body burns at rest. When thyroid output drops (hypothyroidism), metabolism slows, energy drops, and weight creeps up even without changes in diet or exercise.

Hypothyroidism affects roughly 2% of the UK population — around 1.3 million people — and is 10 times more common in women. Subclinical hypothyroidism (TSH elevated but T4 still in range) affects another 5-10% and can cause 2-5 kg of unexplained weight gain.

What to check: TSH is the primary screening marker. If TSH is elevated (>4.0 mIU/L), your GP should then check Free T4 and Free T3 to confirm. The NHS reference range for TSH is 0.27–4.20 mIU/L, but many endocrinologists consider 0.5–2.5 mIU/L optimal for metabolic health.

If abnormal: your GP can prescribe levothyroxine. Even in subclinical cases, NICE guideline NG145 recommends considering treatment if TSH is above 10 mIU/L, or if symptoms are present with TSH between 4 and 10.

Insulin resistance: the hidden metabolic block

Insulin resistance is arguably the single biggest obstacle to fat loss that most people have never heard of. When your cells become less responsive to insulin, your pancreas compensates by producing more of it. High circulating insulin is a powerful fat-storage signal — it actively prevents lipolysis (fat breakdown) and promotes lipogenesis (fat creation).

A 2024 meta-analysis in The Lancet Diabetes & Endocrinology found that individuals with insulin resistance lose 40-60% less weight on the same calorie deficit compared to insulin-sensitive individuals. This isn’t a willpower failure — it’s a metabolic one.

What to check: Fasting insulin is the earliest and most sensitive marker. The NHS rarely tests it (they rely on HbA1c and fasting glucose), but fasting insulin can be elevated for 5-10 years before glucose becomes abnormal. An optimal fasting insulin is 20–60 pmol/L; above 100 pmol/L strongly suggests insulin resistance.

HOMA-IR: if you have both fasting insulin and fasting glucose, you can calculate your HOMA-IR (Homeostatic Model Assessment of Insulin Resistance). A HOMA-IR below 1.0 is optimal; above 2.0 suggests insulin resistance; above 2.9 indicates significant insulin resistance.

If abnormal: resistance training, reducing refined carbohydrates, improving sleep quality, and increasing fibre intake are all evidence-based interventions. A BMJ review (2022) found that resistance training improved insulin sensitivity by 20-40% independent of weight change.

HbA1c: your 3-month blood sugar report card

While fasting insulin catches the earliest metabolic dysfunction, HbA1c tells you how well your body has been managing blood sugar over the past 2-3 months. It measures the percentage of haemoglobin that has glucose attached to it.

NHS thresholds: below 42 mmol/mol (6.0%) is normal; 42–47 mmol/mol (6.0–6.4%) is prediabetes; 48 mmol/mol (6.5%) or above is type 2 diabetes. The prediabetes range is the critical window — the NHS Diabetes Prevention Programme showed that lifestyle changes can reduce type 2 risk by 58% if caught early.

For weight loss, HbA1c is valuable as a progress marker. A drop of 5-10 mmol/mol is common with 5-10% body weight loss and confirms that metabolic health is improving alongside the number on the scale. Read our full HbA1c guide for detailed range interpretation.

Cortisol, chronic stress and visceral fat

Cortisol is your primary stress hormone. In acute bursts it’s protective, but chronically elevated cortisol — from sleep deprivation, work stress, overtraining, or chronic illness — promotes visceral fat accumulation specifically around the abdomen.

A study in Obesity (2017) found a strong positive association between hair cortisol concentration and both BMI and waist circumference. Visceral fat itself produces inflammatory cytokines that further stimulate cortisol production — creating a feedback loop.

What to check: a morning blood cortisol (taken before 9am, ideally before 8am) is the standard screening test. NHS morning reference range is 166–507 nmol/L. Optimal for metabolic health: 280–450 nmol/L. Consistently elevated levels above 550 nmol/L may warrant further investigation for Cushing’s syndrome.

If elevated: sleep optimisation (7-9 hours), stress reduction, and avoiding chronic overtraining are first-line interventions. Our cortisol guide covers the cortisol:DHEA-S ratio and ashwagandha evidence in detail.

Cholesterol and triglycerides: tracking cardiovascular improvement

Weight loss — particularly loss of visceral fat — typically improves your lipid profile. Triglycerides drop, HDL rises, and the proportion of small dense LDL particles decreases. Tracking these changes gives you objective proof that your weight loss is improving health, not just aesthetics.

A NICE CG181 recommends a full lipid profile (total cholesterol, HDL, non-HDL, triglycerides) as part of cardiovascular risk assessment. For a more complete picture, add ApoB — a single number that counts all atherogenic particles and is a better predictor of cardiovascular events than LDL alone.

Key targets: triglycerides below 1.7 mmol/L; HDL above 1.0 mmol/L (men) or 1.2 mmol/L (women); non-HDL cholesterol below 4.0 mmol/L. A 5-10% weight loss typically reduces triglycerides by 15-30% and raises HDL by 5-10%. See our cholesterol guide for full range tables.

Vitamin deficiencies that stall weight loss

Calorie restriction is inherently restrictive of micronutrients too. If you’re already borderline deficient before starting a diet, restriction will push you into outright deficiency — with real consequences for energy, recovery, and fat metabolism.

Vitamin D

The National Diet and Nutrition Survey shows that 1 in 6 UK adults have vitamin D levels below 25 nmol/L (deficient), rising to 1 in 3 in winter. Multiple studies have found an inverse relationship between vitamin D status and BMI — a meta-analysis in Obesity Reviews (2015) confirmed that vitamin D supplementation alongside calorie restriction improved fat loss compared to restriction alone.

Optimal level: 75–125 nmol/L (the NHS only flags below 25 nmol/L). Read our vitamin D deficiency guide.

Iron and ferritin

Low ferritin causes fatigue, exercise intolerance, and impaired thermogenesis — all of which make weight loss harder. Women of reproductive age, vegetarians, and people with heavy menstrual bleeding are at highest risk. The NHS flags ferritin below 15 µg/L, but symptoms often appear below 30 µg/L. Optimal for active adults: 50–150 µg/L. See our iron deficiency guide.

Vitamin B12 and folate

B12 and folate are essential for energy metabolism and red blood cell production. Deficiency causes fatigue that can be indistinguishable from the tiredness of calorie restriction. People on metformin (commonly prescribed alongside weight loss interventions) are at particular risk of B12 depletion — NICE NG28 recommends monitoring B12 in long-term metformin users.

Hormones that affect body composition

Beyond thyroid and cortisol, two hormonal markers are particularly relevant for weight management:

Testosterone

Low testosterone in men is both a cause and consequence of obesity. Visceral fat contains aromatase, an enzyme that converts testosterone to oestradiol — creating a vicious cycle of declining T and increasing fat mass. The BSSM guidelines define testosterone deficiency as total T below 8 nmol/L (definite) or 8–12 nmol/L (borderline, check free testosterone).

Weight loss itself can raise testosterone. A JAMA Internal Medicine study found that a 10% weight loss increased total testosterone by approximately 2.9 nmol/L in obese men.

SHBG (Sex Hormone Binding Globulin)

SHBG binds testosterone and oestrogen, controlling how much is biologically active. Low SHBG is independently associated with insulin resistance, visceral fat, and metabolic syndrome. It’s so tightly correlated with metabolic health that some researchers have proposed it as a screening marker for type 2 diabetes risk. Levels below 30 nmol/L in men or below 40 nmol/L in women warrant further metabolic investigation.

Liver function and non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) affects an estimated 25-30% of the UK adult population, rising to over 70% in people with obesity. The condition is often silent — most people have no symptoms until significant liver damage has occurred.

What to check: ALT (Alanine Aminotransferase) is the most sensitive screening marker for liver cell damage. GGT (Gamma-Glutamyl Transferase) alongside elevated ALT strengthens the case for fatty liver. NICE guideline NG49 recommends liver enzyme testing as part of NAFLD assessment.

The good news: NAFLD is reversible with weight loss. A 7-10% reduction in body weight can resolve steatosis (simple fatty liver) in most cases. Tracking ALT over your weight loss journey provides objective evidence of liver recovery. See our liver function guide for the full panel breakdown.

Inflammation: the hs-CRP connection

Visceral fat is not inert storage — it’s metabolically active tissue that secretes inflammatory cytokines (IL-6, TNF-alpha) which drive chronic low-grade inflammation. This systemic inflammation is measured by high-sensitivity CRP (hs-CRP).

The American Heart Association classifies cardiovascular risk by hs-CRP: below 1.0 mg/L is low risk, 1.0–3.0 mg/L is moderate, above 3.0 mg/L is high. In the context of weight loss, hs-CRP is a powerful progress marker — it drops as visceral fat decreases, often before the scale shows dramatic change.

A landmark Lancet trial (CANTOS, 2017) demonstrated that reducing inflammation independently reduces cardiovascular events, even without lowering cholesterol. Weight loss is one of the most effective ways to lower hs-CRP naturally. See our inflammation guide for intervention strategies ranked by effect size.

NHS GP vs Helvy: what gets tested for weight loss

If you ask your GP for blood tests related to weight loss, what you receive depends on your BMI, symptoms, and local commissioning guidelines. Here’s a realistic comparison:

The gap is clearest for fasting insulin, SHBG, hs-CRP, and ApoB — markers that catch metabolic dysfunction years before standard GP screening. A private weight management panel gives you the full picture in one test, rather than waiting for individual markers to be flagged over multiple appointments.

Blood tests if you’re on Ozempic, Wegovy or Mounjaro

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) are now prescribed to over 1 million people in the UK for weight management. These medications are highly effective but create specific monitoring needs:

• Liver enzymes (ALT, GGT) — GLP-1s can occasionally cause gallbladder complications. Baseline and 3-month liver checks are prudent.
• Kidney function (creatinine, eGFR) — dehydration from reduced appetite can stress the kidneys. Monitor at baseline and during dose escalation.
• Thyroid (TSH) — GLP-1 agonists carry a precautionary thyroid warning based on rodent studies. Pre-treatment thyroid screening is standard practice.
• Nutritional markers (B12, ferritin, vitamin D, folate) — reduced food intake means reduced micronutrient intake. Deficiencies accelerate during rapid weight loss.
• Fasting insulin + HbA1c — the best way to track metabolic improvement alongside weight change.

For a comprehensive GLP-1 monitoring protocol, read our dedicated blood tests for Ozempic, Mounjaro & Wegovy guide. If you’re a woman in perimenopause on GLP-1 medication, our GLP-1 perimenopause guide covers the compounded risks of bone loss, muscle depletion, and gallbladder complications.

Frequently asked questions